Flagship Biotech International is a finished-dose manufacturer based in India. It appears in 98 regulatory filings across 5 regulators, without an active US DMF or CEP on file. Its filings concentrate with DIGEMAPS (DO), MINSA (CR) and ARCSA (EC). Its GMP standing is certified by CDSCO (India). Customs aggregates show $10.2M of exports covering 1,074 molecules to 38 destinations in 2025.
| Site | FDA FEI |
|---|---|
| estatenarodaahmed abad 382 330ahmedabad, India | Not on file |
| kabilpore 396 424navsari, India | Not on file |
| mehsana 382 715, India | Not on file |
| ahmedabad 382 445, India | Not on file |
| ahmedabad, India | Not on file |
| japur highwaydedhrota 383 220sabarkantha, India | Not on file |
3 further sites are on record.
| Regulator | Filings | GMP certificates |
|---|---|---|
| DIGEMAPS (DO) | 91 | None |
| MINSA (CR) | 2 | None |
| ARCSA (EC) | 2 | None |
| UZPHARM (UZ) | 2 | None |
| INFARMED (PT) | 1 | None |
| CDSCO (India) | None | 12 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.2M | 20 |
| 2025 | Not reported | $10.2M | 38 |
| 2024 | Not reported | $10.1M | 46 |
| 2023 | Not reported | $9.5M | 44 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Flagship Biotech International comes back tiered against every other supplier able to file there.
Start for free